IMPAACT 2010
This is a phase III randomised open-label clinical trial assessing virologic efficacy and safety of Dolutegravir-containing versus Efavirenz-containing ART regimens in HIV-1 infected pregnant women and their infants.
Status: Completed
This is a phase III randomised open-label clinical trial assessing virologic efficacy and safety of Dolutegravir-containing versus Efavirenz-containing ART regimens in HIV-1 infected pregnant women and their infants.
Block 5 Mulago Hospital. P.O Box 72052, Kampala, Uganda
Tel: +256-417-119100/200, +256-312 119100
Toll Free: 0800204444 or 0800111011
Kakiza Road, Boma
Fort Portal City
Fort Portal.
Tel: 0483-422143
Regional office,
Plot 52,
Bungokho Road,
Senior Quarters, Mbale City